Showing 65,801 - 65,820 results of 101,767 for search '(( 5 ((c decrease) OR (a decrease)) ) OR ( 5 ((nm decrease) OR (mean decrease)) ))', query time: 1.92s Refine Results
  1. 65801
  2. 65802
  3. 65803

    Analysis of biochemical and membrane property parameters. by Sandeep N. Shah (118905)

    Published 2016
    “…(B) Oxygen binding curves showing filtered (F) and non-filtered (NF) stemRBCs harvested on day 18 of culture and control RBCs (n = 3 each) (mean ± SD). (C) ATP and (D) G6PDH analysis of day 18 non-filtered and filtered stemRBCs (n = 3–5) as well as control and G6PDH standard (n = 8) (mean ± SD). …”
  4. 65804

    Data_Sheet_1_An evaluation of nutrition, culinary, and production interventions using African indigenous vegetables on nutrition security among smallholder farmers in Western Kenya... by Emily V. Merchant (12267842)

    Published 2023
    “…Despite this, post-intervention, households that received NCI/PI had a higher WDDS relative to the control: WDDS 5.1 ± 1.8 vs. 4.2 ± 1.5, p = 0.035. …”
  5. 65805

    DataSheet1_Potential for material valorization of composites (glass fiber in polyester resin) in concrete: performance evaluation on mortar.pdf by Agnès Zambon (19961139)

    Published 2024
    “…Several mix designs were tested in order to understand the impact of introducing composite shreds as a substitute for sand. Composite shreds were introduced in the following ratios by volume: 0, 1, 1.5, 2, 2.5, 3, and 7% with water and cement ratio equal to 0.5, 0.6, and 0.7.…”
  6. 65806

    supplementary figure: Osimertinib inhibits the MYLK4-mediated phosphorylation of CDKAL1 to suppress stemness and chemoresistance in rhabdomyosarcoma by Takuto Itano (16830105)

    Published 2025
    “…<p dir="ltr">Supplementary Figure: Identification of osimertinib as an inhibitor of the MYLK4–CDKAL1–SALL2 axis a (left): RT‒qPCR and immunoblotting of RD cells treated with 40 ng/mL epidermal growth factor (EGF) and 2.5 µM osimertinib for 24 h revealed that osimertinib inhibits SALL2 expression in a translation-dependent manner. …”
  7. 65807

    Immunocytochemistry, RT-PCR and Q-PCR analyses of neonatal ‘RSCs’ during <i>in vitro</i> cultivation. by Magdalena Czekaj (314406)

    Published 2013
    “…<p>Following expansion in the presence of growth factors ‘RSCs’ show immunoreactivity for <i>nestin</i>, <i>Sox2</i> and <i>Pax6</i> at the protein (A) and mRNA levels (B, C). Further gene expression examination using semi-quantitative RT-PCR revealed that throughout all passages analyzed ‘RSCs’ express components of the notch signaling pathway (<i>Notch1</i> receptor, <i>Hes1</i> and <i>Hes5</i>). …”
  8. 65808

    Western blot analysis of claudin-1 and occludin expression after apical treatment with TGFβs. by Angelika Stammler (483878)

    Published 2013
    “…<p>A: Western blot with lysates of MEPC5 after apical stimulation with TGFβ1, TGFβ2 or TGFβ3 compared to untreated cells. …”
  9. 65809

    Screening results using different dilutions of CMBs. by Martin Bonin (17811349)

    Published 2024
    “…As expected, the empty plasmid control shows values close to 0, whereas PesCDA<sup>nm</sup> shows an increasing amount of free primary amines formed with a decreasing dilution of CMBs. …”
  10. 65810

    Biological function of METTL16. by Yuping Liao (598317)

    Published 2024
    “…After 5 days of induction with hemin, relatively few blue-stained cells overexpressed METTL16 (magnification 200×) (<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0306043#pone.0306043.g005" target="_blank">Fig 5k and 5l</a>) (mean with SD). …”
  11. 65811
  12. 65812
  13. 65813
  14. 65814
  15. 65815
  16. 65816
  17. 65817
  18. 65818

    52-Week Efficacy and Safety of Telbivudine with Conditional Tenofovir Intensification at Week 24 in HBeAg-Positive Chronic Hepatitis B by Teerha Piratvisuth (279131)

    Published 2013
    “…Myalgia was more common in the monotherapy group (19% versus 7%). No decrease in the mean glomerular filtration rate occurred in either treatment group at Week 52.…”
  19. 65819
  20. 65820

    Gli1 slowed proliferation of NB cell lines while driving CGNPs to proliferate. by Timothy R. Gershon (258247)

    Published 2009
    “…<p>A) Transduction of <i>Gli1</i> decreased proliferation of NB cell lines SY5Y, BE2(N), BE2(C) and BE2(S). …”